About Zhejiang Daoer Biological Technology
Zhejiang Daoer Biological Technology is a company based in Hangzhou (China) founded in 2014.. Zhejiang Daoer Biological Technology has raised $14.94 million across 2 funding rounds from investors including Kaitai Capital and Zhejiang Huarui Investment Holdings. Zhejiang Daoer Biological Technology operates in a competitive market with competitors including Ardelyx, Carmot, DermBiont, Inozyme Pharma and Kriya Therapeutics, among others.
- Headquarter Hangzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.94 M (USD)
in 2 rounds
-
Latest Funding Round
$14.94 M (USD), Series A
Nov 03, 2020
-
Investors
Kaitai Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Zhejiang Daoer Biological Technology
Zhejiang Daoer Biological Technology has successfully raised a total of $14.94M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14.94 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $14.9M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Series A - Zhejiang Daoer Biological Technology | Valuation | Zhejiang Huarui Investment Holdings | |
| Feb, 2019 | Amount | Series A - Zhejiang Daoer Biological Technology | Valuation | Kaitai Capital Management |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zhejiang Daoer Biological Technology
Zhejiang Daoer Biological Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Kaitai Capital and Zhejiang Huarui Investment Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Kaitai Capital is engaged in innovation investment management services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zhejiang Daoer Biological Technology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zhejiang Daoer Biological Technology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zhejiang Daoer Biological Technology Comparisons
Competitors of Zhejiang Daoer Biological Technology
Zhejiang Daoer Biological Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ardelyx, Carmot, DermBiont, Inozyme Pharma and Kriya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Disease-modifying therapies for metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of treatments for rare and debilitating metabolic diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Therapeutics for infectious and autoimmune diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zhejiang Daoer Biological Technology
Frequently Asked Questions about Zhejiang Daoer Biological Technology
When was Zhejiang Daoer Biological Technology founded?
Zhejiang Daoer Biological Technology was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Where is Zhejiang Daoer Biological Technology located?
Zhejiang Daoer Biological Technology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Is Zhejiang Daoer Biological Technology a funded company?
Zhejiang Daoer Biological Technology is a funded company, having raised a total of $14.94M across 2 funding rounds to date.
What does Zhejiang Daoer Biological Technology do?
Zhejiang Daoer Biologicals is developing protein therapies for metabolic diseases and cancers. The company has proprietary protein drug discovery platforms such as recombinant PEG-like xLONGylation platform, MultiBody platform, and AccuBody platform. The lead candidate, DR10601 is a dual agonist Fc fragment of human IgG4 targeting glucagon receptor and GLP-1 receptor. The candidate is being developed for NASH, obesity, and diabetes (preclinical stage). Also developing antibodies and enzymes for oncology and ophthalmology.
Who are the top competitors of Zhejiang Daoer Biological Technology?
Zhejiang Daoer Biological Technology's top competitors include Ardelyx, Carmot and Vedanta Biosciences.
Who are Zhejiang Daoer Biological Technology's investors?
Zhejiang Daoer Biological Technology has 2 investors. Key investors include Kaitai Capital, and Zhejiang Huarui Investment Holdings.